Teleflex Acquires Innovative Technology for Lung Isolation Procedures; Terms Not Disclosed
Teleflex Incorporated (NYSE: TFX) announced it has acquired the EZ-BlockerTM disposable catheter product line with a unique bifurcated distal end, a novel and patented bronchial blocker for lung isolation and one-lung ventilation. The acquisition is consistent with the company's strategy to invest in late-stage, innovative technology to support its future growth.
The EZ-Blocker, a 7 Fr., 4 lumen, 75 cm, disposable catheter, is designed to enable easy, quick placement with minimal risk of dislocation during surgery, which supports patient safety and allows for simplified performance of bilateral procedures without the disadvantages of existing devices for lung isolation and one lung ventilation. Lung isolation is used to achieve one-lung ventilation to facilitate a variety of thoracic surgical procedures and treatment of conditions of the lungs, heart, chest wall and diaphragm. With the acquisition of EZ-Blocker, Teleflex strengthens its Anesthesia product portfolio.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.